Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

globenewswire

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target – NEWSnet – News… as it used to be

More Press Releases

May 7, 2026

ISS signs agreement to acquire Tomagruppen

May 7, 2026

BloomsburyMoney.com appoints Chris Clarke as Head of Compliance to bolster Jersey operations

May 7, 2026

GEN Korean BBQ Launches Costco Roadshow Series, Marking Next Phase of Retail Expansion

May 7, 2026

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

ISS signs agreement to acquire Tomagruppen

BloomsburyMoney.com appoints Chris Clarke as Head of Compliance to bolster Jersey operations

GEN Korean BBQ Launches Costco Roadshow Series, Marking Next Phase of Retail Expansion

ESET Research uncovers CallPhantom scam on Google Play: Fake logs for real money